@article{64170c0c93e74324a325a03dc5b15173,
title = "Recent advances in systemic targeted therapy for cutaneous T-cell lymphoma",
author = "Lewis, {Daniel J.} and Kim, {Ellen J.} and Madeleine Duvic",
note = "Funding Information: EJ Kim has received research grants from Kyowa Hakko Kirin, Solgenix, Inc., and Actelion Pharmaceuticals US, Inc. She has served as an advisor or consultant for Actelion Pharmaceuticals US, Inc. M Duvic has received research grants from Allos Therapeutics, Inc., Angimmune LLC, BioChryst Pharmaceuticals, Eli Lilly and Company, Eisai Inc., Innate Pharma S.A., Kyowa Hakko Kirin Pharma, Inc., Merck & Co., miRagen Therapeutics, Roche Holding AG, Seattle Genetics, Inc., Solgenix, Inc., TetraLogic Pharmaceuticals, and Therakos, Inc. She has served as an advisor or consultant for Allos Therapeutics, Inc., Eisai Inc., Kyowa Hakko Kirin Pharma, Inc., Millennium Pharmaceuticals, Inc., miRagen Therapeutics, and Seattle Genetics, Inc. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.",
year = "2017",
month = sep,
day = "22",
doi = "10.1080/14656566.2017.1367594",
language = "English (US)",
volume = "18",
pages = "1535--1536",
journal = "Expert opinion on pharmacotherapy",
issn = "1465-6566",
publisher = "Informa Healthcare",
number = "14",
}